Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development

The four serotypes of dengue virus (DENV) are the leading cause of arboviral diseases in humans. Decades of efforts have made remarkable progress in dengue vaccine development. Despite the first dengue vaccine (dengvaxia from Sanofi Pasteur), a live-attenuated tetravalent chimeric yellow fever-dengu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Wen-Yang, Lin, Hong-En, Wang, Wei-Kung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517401/
https://www.ncbi.nlm.nih.gov/pubmed/28775720
http://dx.doi.org/10.3389/fmicb.2017.01372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517401/
https://www.ncbi.nlm.nih.gov/pubmed/28775720
http://dx.doi.org/10.3389/fmicb.2017.01372

Ejemplares similares